サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：尿検査市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年
市場調査レポート
商品コード
1326509

尿検査市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年

Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Product, By Test Type, By Application, By End user, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

尿検査市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

尿検査市場は、2024年から2028年の予測期間において目覚ましいCAGRで成長すると予想されます。

これは、糖尿病、腎臓病などの慢性疾患の有病率の増加などの要因によるものです。

慢性疾患の有病率の上昇

糖尿病などの慢性疾患の有病率は世界的に増加しており、世界中の人々の間に大きな健康上の懸念を引き起こしています。例えば、国家糖尿病統計報告書によると、2020年には18歳以上の約3,420万人が糖尿病に罹患しています。例えば、全国糖尿病統計報告書によると、2020年には18歳以上の約3420万人が糖尿病に罹患するとされています。また、人口の約3分の1が、常に血圧と血糖値が上昇し、腎臓に何らかの合併症を患っています。不健康な食品の摂取、アルコール摂取、加工食品摂取の増加、運動不足などを含む座りがちなライフスタイルが、世界中で糖尿病有病率の上昇につながっています。糖尿病患者のグルコースレベルを特定するため、あるいは個人の糖尿病発症を確認するために、尿検査は重要なステップであり、世界中で頻繁に実施されています。

尿路感染症（UTI）の負担増

尿検査は尿路感染症（UTI）を特定するための診断手順として一般的に利用されています。この診断法では、細胞、細菌、ウイルス、タンパク質、クレアチニン、異常な濃度で存在する物質を検出・同定することにより、尿を検査します。尿路結石の最も一般的な原因は、細菌が尿道から尿路に入り、膀胱内で繁殖し始めることです。最も一般的な尿路感染症は膀胱炎（膀胱炎）です。腎感染症（多発性腎炎）の診断にも使用されることがあります。一般的に観察される尿路結石のリスク上昇は、尿路結石の既往、妊娠、年齢（高齢者は尿路結石の有病率が高い）、更年期、不衛生などに起因する可能性があり、これが、予測期間中に市場が成長することを後押ししています。

家庭用尿検査キットの人気

家庭用尿検査キットは、自宅で尿路感染症の有無を検査するために利用できます。尿路感染症検査キットは一般的に妊娠検査キットとして機能し、自宅で数分で尿路感染症の存在を示します。また、これらの検査キットは、尿路感染症の再発をテストするために非常に有益であり、それによってそれを治すためのさらなる措置を取る。さらに、これらの検査キットは、100％のプライバシーで尿薬物検査のための自宅スクリーニングを提供します。キットは、マリファナ、コカイン、メタンフェタミンなどを診断するために設計されています。この尿薬物検査キットは、家庭での薬物検査、職場での検査、学校、大学、大学の薬物検査、法執行機関の検査、実質的な薬物乱用検査などに適した在宅検査が可能です。

利用可能なカスタマイズ

所定のMarketdataで、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 尿検査の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ別
    • 用途別
    • エンドユーザー別
    • 企業別
    • 地域別
  • 製品市場マップ

第6章 アジア太平洋地域の尿検査市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ
    • アプリケーション
    • エンドユーザー
    • 国別
  • アジア太平洋地域国別分析
    • 中国.
    • インド .
    • 韓国.
    • 日本
    • オーストラリア

第7章 欧州の尿検査市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ
    • アプリケーション
    • エンドユーザー
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 北米の尿検査市場の展望。

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ
    • アプリケーション
    • エンドユーザー
    • 国別
  • 北米国別分析
    • 米国の尿検査市場の展望
      • 市場規模・予測
        • 金額別
      • 市場シェアと予測
        • 製品別
        • 検査タイプ
        • アプリケーション
        • エンドユーザー
    • メキシコの尿検査市場の展望
      • 市場規模・予測
        • 金額別
      • 市場シェアと予測
        • 製品別
        • 検査タイプ
        • アプリケーション
        • エンドユーザー
    • カナダの尿検査市場の展望
      • 市場規模・予測
        • 金額別
      • 市場シェアと予測
        • 製品別
        • 検査タイプ
        • アプリケーション
        • エンドユーザー

第9章 南米の尿検査市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ
    • アプリケーション
    • エンドユーザー
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの尿検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 検査タイプ
    • アプリケーション
    • エンドユーザー
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品開発

第13章 競合情勢

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（In case of listed companies）
  • Recent Developments
  • SWOT Analysis
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG.
    • Abbott Laboratories
    • Cardinal Health Inc.
    • Danaher Corporation
    • Sysmex Corporation
    • Quidel Corporation
    • Becton, Dickinson & Company
    • Bio-Rad Laboratories Inc.
    • EKF Diagnostic s Holdings plc

第14章 戦略的提言

目次
Product Code: 15094

Urinalysis Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing chronic disease prevalence, such as diabetes, kidney disease, etc.

Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine. This test is utilized to detect and manage syndromes of diseases, such as kidney disease, urinary tract infections, and diabetes. Further, urinalysis being informative and a non-invasive diagnostic method for the identification of kidney disease propels the market demand for urinalysis and adds to the market growth.

Moreover, rising awareness of kidney and urinary tract infections among the population and increasing government initiatives, along with growing healthcare investments for the identification and management of the growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.

Rising Prevalence of Chronic Diseases

Rising chronic disease prevalence such as diabetes is increasing worldwide, causing a huge health concern among the population around the world; for instance, according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. And above were affected with diabetes. Also, around one-third of the population was suffering some kind of kidney complication due to constant elevated blood pressure and blood sugar. The sedentary lifestyle, including consumption of unhealthy foods, alcohol consumption, increased processed food intake, lack of exercise, etc., is leading to the rising prevalence of diabetes around the world. To identify the glucose level in diabetic people or to confirm the diabetes occurrence in an individual, urinalysis is an important step and is frequently performed across the globe.

Growing Burden of Urinary Tract Infections (UTIs)

Urinalysis is a commonly utilized diagnostic procedure in the identification of a Urinary Tract infection (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, viruses, proteins, creatinine, and substances present in abnormal concentration. The most common cause of UTIs is when bacteria enter the urinary tract via the urethra and start flourishing in the bladder. The most common type of urine infection is bladder infection (cystitis). It can be used for the diagnosis of kidney infection (polynephritis). The rising risk of commonly observed UTI can be due to a previous UTI, pregnancy, age (older adults have increased UTI prevalence), menopause, poor hygiene, etc., and this is, in turn, supporting the market growth anticipated to boost in the forecast period.

The popularity of at-home Urine Testing Kits

At-home urine test kits are available for testing the presence of urinary tract infections at home. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in a few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at-home screening for urine drug tests with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is available for home-based tests suitable for home drug testing, workplace testing, school, college, and university drug testing, law enforcement testing, substantial drug abuse testing, etc.

Recent Development

In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offers dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.

Market Segmentation

Global Urinalysis Market is segmented based on the product, test type, application, end-user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc, etc.., are some of the major players operating in the global Urinalysis Market.

Report Scope

In this report, Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Urinalysis Market, By Product:

  • Consumables
  • Instruments

Urinalysis Market, By Test Type:

  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

Urinalysis Market, By Application:

  • Disease Screening
  • Pregnancy & Fertility

Urinalysis Market, By End User:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

Urinalysis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Urinalysis Market.

Available Customizations

With the given Marketdata, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urinalysis Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables & Instruments)
    • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
    • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
    • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Urinalysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Product
    • 6.2.2. Test Type
    • 6.2.3. Application
    • 6.2.4. End user
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Urinalysis Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Product
        • 6.3.1.2.2. Test Type
        • 6.3.1.2.3. Application
        • 6.3.1.2.4. End user
    • 6.3.2. India Urinalysis Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Product
        • 6.3.2.2.2. Test Type
        • 6.3.2.2.3. Application
        • 6.3.2.2.4. End user
    • 6.3.3. South Korea Urinalysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Product
        • 6.3.3.2.2. Test Type
        • 6.3.3.2.3. Application
        • 6.3.3.2.4. End user
    • 6.3.4. Japan Urinalysis Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Product
        • 6.3.4.2.2. Test Type
        • 6.3.4.2.3. Application
        • 6.3.4.2.4. End user
    • 6.3.5. Australia Urinalysis Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Product
        • 6.3.5.2.2. Test Type
        • 6.3.5.2.3. Application
        • 6.3.5.2.4. End user

7. Europe Urinalysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product
    • 7.2.2. Test Type
    • 7.2.3. Application
    • 7.2.4. End user
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Urinalysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product
        • 7.3.1.2.2. Test Type
        • 7.3.1.2.3. Application
        • 7.3.1.2.4. End user
    • 7.3.2. Germany Urinalysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product
        • 7.3.2.2.2. Test Type
        • 7.3.2.2.3. Application
        • 7.3.2.2.4. End user
    • 7.3.3. United Kingdom Urinalysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product
        • 7.3.3.2.2. Test Type
        • 7.3.3.2.3. Application
        • 7.3.3.2.4. End user
    • 7.3.4. Italy Urinalysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product
        • 7.3.4.2.2. Test Type
        • 7.3.4.2.3. Application
        • 7.3.4.2.4. End user
    • 7.3.5. Spain Urinalysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product
        • 7.3.5.2.2. Test Type
        • 7.3.5.2.3. Application
        • 7.3.5.2.4. End user

8. North America Urinalysis Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product
    • 8.2.2. Test Type
    • 8.2.3. Application
    • 8.2.4. End user
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Urinalysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product
        • 8.3.1.2.2. Test Type
        • 8.3.1.2.3. Application
        • 8.3.1.2.4. End user
    • 8.3.2. Mexico Urinalysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product
        • 8.3.2.2.2. Test Type
        • 8.3.2.2.3. Application
        • 8.3.2.2.4. End user
    • 8.3.3. Canada Urinalysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product
        • 8.3.3.2.2. Test Type
        • 8.3.3.2.3. Application
        • 8.3.3.2.4. End user

9. South America Urinalysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Type
    • 9.2.2. Product Type
    • 9.2.3. Tissue
    • 9.2.4. End user
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Urinalysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product
        • 9.3.1.2.2. Test Type
        • 9.3.1.2.3. Application
        • 9.3.1.2.4. End user
    • 9.3.2. Argentina Urinalysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product
        • 9.3.2.2.2. Test Type
        • 9.3.2.2.3. Application
        • 9.3.2.2.4. End user
    • 9.3.3. Colombia Urinalysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product
        • 9.3.3.2.2. Test Type
        • 9.3.3.2.3. Application
        • 9.3.3.2.4. End user

10. Middle East and Africa Urinalysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product
    • 10.2.2. Test Type
    • 10.2.3. Application
    • 10.2.4. End user
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Urinalysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product
        • 10.3.1.2.2. Test Type
        • 10.3.1.2.3. Application
        • 10.3.1.2.4. End user
    • 10.3.2. Saudi Arabia Urinalysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product
        • 10.3.2.2.2. Test Type
        • 10.3.2.2.3. Application
        • 10.3.2.2.4. End user
    • 10.3.3. UAE Urinalysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product
        • 10.3.3.2.2. Test Type
        • 10.3.3.2.3. Application
        • 10.3.3.2.4. End user
    • 10.3.4. Kuwait Urinalysis Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Product
        • 10.3.4.2.2. Test Type
        • 10.3.4.2.3. Application
        • 10.3.4.2.4. End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. F. Hoffmann-La Roche Ltd.
    • 13.6.2. Siemens Healthineers AG.
    • 13.6.3. Abbott Laboratories
    • 13.6.4. Cardinal Health Inc.
    • 13.6.5. Danaher Corporation
    • 13.6.6. Sysmex Corporation
    • 13.6.7. Quidel Corporation
    • 13.6.8. Becton, Dickinson & Company
    • 13.6.9. Bio-Rad Laboratories Inc.
    • 13.6.10. EKF Diagnostic s Holdings plc

14. Strategic Recommendations